Myositis Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceOften deficient in autoimmune diseases; supports immune modulation and muscle function
Supporting Studies (1)
Supports muscle energy and may help maintain muscle mass during disease activity
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsAnti-inflammatory properties; may help modulate immune response
Supporting Studies (1)
Supports mitochondrial function in muscle cells; antioxidant
Supporting Studies (1)
Supports bone health; corticosteroid treatment increases osteoporosis risk
Supporting Studies (1)
Supports muscle protein synthesis and maintenance during inflammatory states
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Myositis refers to a group of rare conditions characterized by chronic muscle inflammation, leading to muscle weakness. The main types are dermatomyositis, polymyositis, and inclusion body myositis.
TYPES:
SYMPTOMS:
CRITICAL: Myositis requires comprehensive medical management. This protocol is SUPPORTIVE ONLY.
MEDICAL TREATMENTS:
ASSOCIATED CONDITIONS:
MONITORING:
* Vitamin D supports muscle function and immune modulation.
* Calcium is important for bone health on corticosteroids.
* Adequate protein helps maintain muscle mass.
Expected timeline: Medical treatment response varies (weeks to months). Supplements support overall health during treatment.
Clinical Perspective
Myositis: Inflammatory myopathies - dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM), immune-mediated necrotizing myopathy (IMNM). Autoantibodies help classify and predict complications (anti-Jo-1, anti-Mi-2, anti-MDA5, etc.). Key features: proximal weakness, elevated CK, EMG abnormalities, muscle biopsy findings.
CRITICAL: Corticosteroids are first-line. Steroid-sparing agents: methotrexate, azathioprine, mycophenolate, rituximab, IVIG. IBM less responsive to immunotherapy. Screen for ILD (pulmonary function, HRCT). Malignancy screening in DM (especially adults). Physical therapy essential. Supplements address nutritional deficiencies and support muscle/bone health - adjunctive only.
* Vitamin D (B-grade): Immune modulation. Systematic review: (PMID: 28750270). 2000-4000 IU daily.
* Creatine (C-grade): Muscle energy. Review: (PMID: 28615996). 5-10g daily.
* Omega-3 (C-grade): Anti-inflammatory. Systematic review: (PMID: 27840029). 2-4g EPA+DHA daily.
* CoQ10 (C-grade): Mitochondrial support. Review: (PMID: 24268541). 100-300mg daily.
* Calcium (B-grade): Bone health. Guidelines: (PMID: 28332116). 1000-1200mg daily.
* Protein (C-grade): Muscle maintenance. Review: (PMID: 28698222). 1.2-1.5g/kg/day.
Assessment targets: Muscle strength (MMT), CK levels, functional status, PFTs, bone density.
Protocol notes: Corticosteroids: high-dose initially (1mg/kg), slow taper over months. Steroid-sparing: start early to minimize steroid exposure. IBM: progressive despite treatment; maintain function with PT. ILD: anti-MDA5 associated with rapidly progressive ILD; aggressive treatment needed. Malignancy: CT chest/abdomen/pelvis, age-appropriate cancer screening. PT/exercise: gentle during active disease; progressive as controlled. Dysphagia: assess swallowing; may need modified diet. Osteoporosis prevention: calcium, vitamin D, bisphosphonate if high risk. Calcinosis: difficult to treat; may try diltiazem. Autoantibodies: myositis-specific antibodies guide prognosis and monitoring.